HIF1A and COVID-19: Therefore, the dysfunctional antibody production occurring in COVID-19 might possibly be related to B cell hypoxic damage [49]; a jammed antibody production by B cells caused by hypoxia and prolonged HIF-1 signaling activation could explain why some subjects, despite having contracted the virus, do not have a neutralization immunoconversion [50].